ROUGIER INC has a total of 12 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and biotechnology are SYNTHESIA A S, LI ZHONGKUN and CHEMICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Polysaccharides | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Sikorska Hanna | 6 |
#2 | Dumoulin Yves | 4 |
#3 | Carriere Francois | 3 |
#4 | Savoie Sylvine | 3 |
#5 | Desjardins Roger | 2 |
#6 | Shestowsky William S | 2 |
#7 | Ingenito Andre | 2 |
#8 | Carriere François | 1 |
#9 | Kowalik Maria | 1 |
#10 | Hebert Manon | 1 |
Publication | Filing date | Title |
---|---|---|
AU8724198A | Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents | |
US5807575A | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds | |
US5264556A | Monoclonal antibodies for measuring okadaic acid | |
WO9015329A1 | Monoclonal antibody specific to ventricular myosin light chain1 and enzyme immunoassay for its detection in cardiac patients | |
CA1330545C | Characteristics and use of the anti-cea antibody produced by the hybridoma having the atcc number hbl0029 | |
CA1339469C | Production and characteristics of anti-anti-cea antibody | |
CA1311700C | Production and characteristics of anti-myosin mouse monoclonal antibody | |
CA824650A | Suppository | |
CA684559A | Process for the preparation of polyvinyl pyrrolidone-iodine compositions |